{
    "organizations": [],
    "uuid": "78a8211861c90f7f91a6515cf1abee5a89bd3148",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-caladrius-biosciences-entered-comm/brief-caladrius-biosciences-entered-common-stock-sales-agreement-with-h-c-wainwright-co-idUSFWN1PY1NZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Caladrius Biosciences Entered Common Stock Sales Agreement With H.C. Wainwright & Co",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Caladrius Biosciences Inc:\n* CALADRIUS BIOSCIENCES INC - ENTERED INTO A COMMON STOCK SALES AGREEMENT WITH H.C. WAINWRIGHT & CO HAVING AGGREGATE OFFERING PRICE OF UP TO $12 MILLION Source text: ( bit.ly/2ER7sY9 ) Further company coverage:\n ",
    "published": "2018-02-09T07:55:00.000+02:00",
    "crawled": "2018-02-09T03:09:18.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "caladrius",
        "bioscience",
        "inc",
        "caladrius",
        "bioscience",
        "inc",
        "entered",
        "common",
        "stock",
        "sale",
        "agreement",
        "wainwright",
        "co",
        "aggregate",
        "offering",
        "price",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}